Professor David Paterson
Director
UQ Centre for Clinical Research Faculty of Medicine

Featured projects | Duration |
---|---|
Culture-independent metagenomic diagnostics Genome Innovation Hub Collaborative Project (UQ infrastructure) |
2021 |
Book Chapters
Paterson, David L. and Bonomo, Robert A. (2019). Multidrug-resistant gram-negative pathogens: the urgent need for 'old' polymyxins. Polymyxin antibiotics: from laboratory bench to bedside. (pp. 9-13) edited by Jian Li, Roger L. Nation and Keith S. Kaye. Cham, Switzerland: Springer. doi: 10.1007/978-3-030-16373-0_2
Paterson, David L. and Doi, Yohei (2017). Cefaclor, cefprozil, and loracarbef. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 376-382) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Henderson, Andrew, Kim, Baek-Nam and Paterson, David L. (2017). Ceftobiprole. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 619-635) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Paterson, David L. (2017). Cefiderocol (S-649266). Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 658-659) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Kim, Baek-Nam, Peri, Anna Maria and Paterson, David L. (2017). Ceftriaxone. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 464-529) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Baba, Hisashi and Paterson, David L. (2017). Cefotiam, cefuzonam, cefamandole, cefonicid, and ceforanide. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 396-402) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Yilmaz, Mesut and Paterson, David L. (2017). Ceftizoxime, cefdinir, cefditoren, cefpodoxime, ceftibuten, cefsulodin, and cefpiramide. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 530-538) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Hayashi, Yoshiro and Paterson, David L. (2017). Imipenem-cilastatin and imipenem-relebactam. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 663-696) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Paterson, David L. (2017). Cefadroxil, cephaloridine, cephacetrile, cephapirin, cephradine, and other rarely used first-generation cephalosporins. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 370-375) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Grayson, M. Lindsay, Cosgrove, Sara E., Crowe, Suzanne M., McCarthy, James S., Hope, William, Mills, John, Mouton, Johan W. and Paterson, David L. (2017). Principles of antimicrobial use. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 3-8) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Kim, Baek-Nam and Paterson, David L. (2017). Cefotaxime. Kucers’ the use of antibiotics: A clinical review of antibacterial, antifungal, antiparasitic, and antiviral drugs. (pp. 426-463) edited by M. Lindsay Grayson, Sara E. Cosgrove, Suzanne Crowe, William Hope, James S. McCarthy, John Mills, Johan W. Mouton and David L. Paterson. Boca Raton, FL United States: CRC Press. doi: 10.1201/9781315152110
Hayashi, Yoshiro and Paterson, David L. (2011). The epidemiology of pan/extreme drug resistance. Antibiotic policies: controlling hospital acquired infection. (pp. 27-38) edited by Ian M. Gould and Jos W.M. van der Meer. New York, United States: Springer. doi: 10.1007/978-1-4419-1734-8_3
Paterson, David L. (2011). Infections due to other members of the enterobacteriaceae, including management of multidrug-resistant strains. Goldman's Cecil medicine. (pp. 1874-1877) edited by Lee Goldman and Andrew I. Schafer. Philadelphia, PA, United States: Elsevier Saunders. doi: 10.1016/B978-1-4377-1604-7.00313-4
Paterson, David L., Sidjabat, Hanna E. and Doi, Yohei (2010). Global spread of multidrug-resistant gram-negative bacilli. Emerging infections 9. (pp. 213-222) edited by W. Michael Scheld, M. Lindsay Grayson and James M. Hughes. Washington, United States: ASM Press. doi: 10.1128/9781555816803.ch10
Paterson, D. L. and Doi, Y. (2010). Infections with Organisms Producing Extended-Spectrum beta-Lactamase. Antimicrobial resistance: beyond the breakpoint. (pp. 21-34) edited by J. T. Weber. Basel, Switzerland: Karger. doi: 10.1159/000298754
DePestel, D., Hayashi, Y. and Paterson, D. L. (2010). Doripenem. Kucers' The Use of Antibiotic. (pp. 514-525) edited by M. Lindsay Grayson, Alvis Kucers and Suzanne Crowe. London, Engalnd, U.K.: Hodder Education.
Hayashi, Y. and Paterson, D.L. (2010). Imipenem. Kucers' the use of antibiotics. (pp. 471-499) edited by M. Lindsay Grayson. London, UK: Hodder Education.
Silveira, Fernanda P. and Paterson, David L. (2007). Management of infections in living-donor transplant recipients. Living Donor Transplantation. (pp. 363-378) CRC Press.
Paterson, David L. and Boots, Robert J. (2000). Aspergillus. Fungal diseases of the lung. (pp. 123-162) edited by George A. Sarosi and Scott F. Davies.. Philadelphia: Lippincott Williams and Wilkins.
Journal Articles
Delgarm Shams-Abadi, Ali, Mohammadian-Hafshejani, Abdollah, Paterson, David L., Arash, Rezvan, Asadi Farsani, Elham, Taji, Asieh, Heidari, Hamid and Shahini Shams Abadi, Milad (2023). The prevalence of colistin resistance in clinical Stenotrophomonas maltophilia isolates worldwide: a systematic review and meta-analysis. BMC Microbiology, 23 (1) 200. doi: 10.1186/s12866-023-02950-6
Peri, Anna Maria, O’Callaghan, Kevin, Rafiei, Nastaran, Graves, Bianca, Sinclair, Holly, Brischetto, Anna, Lim, Karen, Parkes-Smith, Jill, Eustace, Matthew, Davidson, Natalie, Tabah, Alexis, Stewart, Adam, Chatfield, Mark D, Harris, Patrick NA and Paterson, David L (2023). Persistence of detectable pathogens by culture independent systems (T2 Magnetic Resonance) in patients with bloodstream infection: prognostic role and possible clinical implications. Clinical Infectious Diseases. doi: 10.1093/cid/ciad663
Peri, Anna Maria, Edwards, Felicity, Henden, Andrea, Harris, Patrick N. A., Chatfield, Mark D., Paterson, David L. and Laupland, Kevin B. (2023). Bloodstream infections in neutropenic and non-neutropenic patients with haematological malignancies: epidemiological trends and clinical outcomes in Queensland, Australia over the last 20 years. Clinical and Experimental Medicine. doi: 10.1007/s10238-023-01206-x
Aslan, Abdullah Tarık, Ezure, Yukiko, Horcajada, Juan Pablo, Harris, Patrick N. A. and Paterson, David L. (2023). In vitro, in vivo and clinical studies comparing the efficacy of ceftazidime-avibactam monotherapy with ceftazidime-avibactam-containing combination regimens against carbapenem-resistant Enterobacterales and multidrug-resistant Pseudomonas aeruginosa isolates or infections: a scoping review. Frontiers in Medicine, 10 1249030. doi: 10.3389/fmed.2023.1249030
Boutzoukas, Angelique E., Komarow, Lauren, Chen, Liang, Hanson, Blake, Kanj, Souha S., Liu, Zhengyin, Salcedo Mendoza, Soraya, Ordoñez, Karen, Wang, Minggui, Paterson, David L., Evans, Scott, Ge, Lizhao, Giri, Abhigya, Hill, Carol, Baum, Keri, Bonomo, Robert A., Kreiswirth, Barry, Patel, Robin, Arias, Cesar A., Chambers, Henry F., Fowler, Vance G. and van Duin, David (2023). International Epidemiology of Carbapenemase-Producing Escherichia coli. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 77 (4), 499-509. doi: 10.1093/cid/ciad288
Mo, Yin, Ying, Ding, Cao, Yang, Hopkins, Jill, Ashley, Elizabeth A., Waithira, Naomi, Wannapinij, Prapass, Lee, Sue J., Paterson, David L., Doorn, H. Rogier van and Turner, Paul (2023). ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance. Wellcome Open Research, 8 179, 179. doi: 10.12688/wellcomeopenres.19210.2
Stewart, Adam G., Heney, Claire, Paterson, David L., Harris, Patrick N.A., Edwards, Felicity and Laupland, Kevin B. (2023). Scedosporium species and Lomentospora prolificans fungaemia is uniformly fatal in patients with haematological malignancy. Internal Medicine Journal, 53 (8), 1489-1491. doi: 10.1111/imj.16198
Atamna, Alaa, Margalit, Ili, Ayada, Gida, Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G., Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Fattah, Manal Abdel, Haquin, Justine, Macgowan, Alasdair, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L., Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodríguez-Baño, Jesús, de Cueto, Marina, Oliver, Antonio, de Gopegui, Enrique Ruiz ... Yahav, Dafna (2023). Outcomes of octogenarians and nonactogenarians with Pseudomonas aeruginosa bacteremia: a multicenter retrospective study. Infection, 51 (4), 1003-1012. doi: 10.1007/s15010-022-01973-x
Denny, Kerina J., Lea, Rodney A., Lindell-Innes, Ross, Haupt, Larisa M., Heffernan, Aaron J., Harvey, Nicholas R., Hughes, Oliver, Cao, Van T., Stuart, Janine, Paterson, David L., McNamara, John F., Ungerer, Jacobus P.J., Pretorius, Carel J., Griffiths, Lyn R. and Lipman, Jeffrey (2023). Diagnosing sepsis in the ICU: comparison of a gene expression signature to pre-existing biomarkers. Journal of Critical Care, 76 154286, 1-6. doi: 10.1016/j.jcrc.2023.154286
Khatri, Dipti, Freeman, Christopher, Falconer, Nazanin, Catapan, Soraia De Camargo, Gray, Len and Paterson, David L. (2023). Clinical impact of Antibiograms as an intervention to optimise antimicrobial prescribing and patient outcomes – a Systematic Review. American Journal of Infection Control. doi: 10.1016/j.ajic.2023.08.013
Lian, Zheng Jie, Phan, Minh-Duy, Hancock, Steven J., Nhu, Nguyen Thi Khanh, Paterson, David L. and Schembri, Mark A. (2023). Genetic basis of I-complex plasmid stability and conjugation. PLoS Genetics, 19 (6) e1010773, 1-21. doi: 10.1371/journal.pgen.1010773
Stewart, Adam G., Chen, Sharon C.-A., Hamilton, Kate, Harris-Brown, Tiffany, Korman, Tony M., Figtree, Melanie, Worth, Leon J., Kok, Jen, Van der Poorten, David, Byth, Karen, Slavin, Monica A. and Paterson, David L. (2023). Clostridioides difficile infection: clinical practice and health outcomes in six large tertiary hospitals in Eastern Australia. Open Forum Infectious Diseases, 10 (6) ofad232. doi: 10.1093/ofid/ofad232
Isler, Burcu, Aslan, Abdullah Tarık, Benli, Burhan Sami, Paterson, David L., Daneman, Nick, Fowler, Robert and Akova, Murat (2023). Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians. International Journal of Antimicrobial Agents, 61 (6) 106802, 1-5. doi: 10.1016/j.ijantimicag.2023.106802
Permana, Budi, Harris, Patrick N. A., Runnegar, Naomi, Lindsay, Margaret, Henderson, Belinda C., Playford, E. G., Paterson, David L., Beatson, Scott A. and Forde, Brian M. (2023). Using genomics to investigate an outbreak of vancomycin-resistant Enterococcus faecium ST78 at a large tertiary hospital in Queensland. Microbiology Spectrum, 11 (3) e0420422, 1-10. doi: 10.1128/spectrum.04204-22
Laupland, Kevin B., Edwards, Felicity, Furuya-Kanamori, Luis, Paterson, David L. and Harris, Patrick N. A. (2023). Bloodstream infection and colorectal cancer risk in Queensland Australia, 2000-2019. The American Journal of Medicine, 136 (9), 896-901. doi: 10.1016/j.amjmed.2023.05.003
Stewart, Adam G, Bauer, Michelle J, Butkiewicz, Dominika, Hinton, Alexandra, Henderson, Andrew, Harris, Patrick NA and Paterson, David L (2023). In vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial. International Journal of Antimicrobial Agents, 62 (2) 106858, 106858. doi: 10.1016/j.ijantimicag.2023.106858
Walczak, Andrew, McCarthy, Kate and Paterson, David L. (2023). A contemporary case series of Pseudomonas aeruginosa infective endocarditis. Medicine, 102 (13) e32662, 1-5. doi: 10.1097/md.0000000000032662
Mu, Andre, Klare, William P., Baines, Sarah L., Ignatius Pang, C. N., Guérillot, Romain, Harbison-Price, Nichaela, Keller, Nadia, Wilksch, Jonathan, Nhu, Nguyen Thi Khanh, Phan, Minh-Duy, Keller, Bernhard, Nijagal, Brunda, Tull, Dedreia, Dayalan, Saravanan, Chua, Hwa Huat Charlie, Skoneczny, Dominik, Koval, Jason, Hachani, Abderrahman, Shah, Anup D., Neha, Nitika, Jadhav, Snehal, Partridge, Sally R., Cork, Amanda J., Peters, Kate, Bertolla, Olivia, Brouwer, Stephan, Hancock, Steven J., Álvarez-Fraga, Laura, De Oliveira, David M. P. ... Walker, Mark J. (2023). Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria. Nature Communications, 14 (1) 1530, 1-21. doi: 10.1038/s41467-023-37200-w
Laupland, Kevin B., Edwards, Felicity, Harris, Patrick N. A. and Paterson, David L. (2023). Significant clinical differences but not outcomes between Klebsiella aerogenes and Enterobacter cloacae bloodstream infections: a comparative cohort study. Infection, 51 (5), 1445-1451. doi: 10.1007/s15010-023-02010-1
Billot, Laurent, Lipman, Jeffrey, Brett, Stephen J., De Waele, Jan J., Cotta, Menino Osbert, Davis, Joshua S., Finfer, Simon, Hammond, Naomi, Knowles, Serena, McGuinness, Shay, Myburgh, John, Paterson, David L., Peake, Sandra, Rajbhandari, Dorrilyn, Rhodes, Andrew, Roberts, Jason A., Roger, Claire, Shirwadkar, Charudatt, Starr, Therese, Taylor, Colman and Dulhunty, Joel M. (2023). Corrigendum to “Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis” [Crit Care Resusc 23(3) (2021) 273–284]. Critical Care and Resuscitation, 25 (1), 60. doi: 10.1016/j.ccrj.2023.04.012
Ling, Weiping, Paterson, David L., Harris, Patrick N. A., Furuya-Kanamori, Luis, Edwards, Felicity and Laupland, Kevin B. (2023). Population-based incidence and characteristics of adult Escherichia coli bloodstream infection in Queensland, Australia from 2000 to 2019. Open Forum Infectious Diseases, 10 (3) ofad071. doi: 10.1093/ofid/ofad071
Reyes, Jinnethe, Komarow, Lauren, Chen, Liang, Ge, Lizhao, Hanson, Blake M., Cober, Eric, Herc, Erica, Alenazi, Thamer, Kaye, Keith S., Garcia-Diaz, Julia, Li, Lanjuan, Kanj, Souha S., Liu, Zhengyin, Oñate, Jose M., Salata, Robert A., Marimuthu, Kalisvar, Gao, Hainv, Zong, Zhiyong, Valderrama-Beltrán, Sandra L., Yu, Yunsong, Tambyah, Paul, Weston, Gregory, Salcedo, Soraya, Abbo, Lillian M., Xie, Qing, Ordoñez, Karen, Wang, Minggui, Stryjewski, Martin E., Munita, Jose M. ... Satlin, Michael (2023). Global epidemiology and clinical outcomes of carbapenem-resistant Pseudomonas aeruginosa and associated carbapenemases (POP): a prospective cohort study. The Lancet Microbe, 4 (3), e159-e170. doi: 10.1016/S2666-5247(22)00329-9
Schults, Jessica, Edwards, Felicity, Charles, Karina, Irwin, Adam D., Rickard, Claire M., Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin (2023). Evolving insights into the epidemiology of Moraxella species bloodstream infection from two decades of surveillance in Queensland, Australia. European Journal of Clinical Microbiology and Infectious Diseases, 42 (2), 209-216. doi: 10.1007/s10096-022-04540-2
Isler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem, Akova, Murat ... Harris, Patrick N. A. (2023). Higher rates of cefiderocol resistance among NDM producing Klebsiella bloodstream isolates applying EUCAST over CLSI breakpoints. Infectious Diseases, 55 (9), 607-613. doi: 10.1080/23744235.2023.2226709
Isler, Burcu, Falconer, Caitlin, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Forde, Brian, Harris, Patrick, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem, Akova, Murat ... Paterson, David L. (2022). High prevalence of ArmA-16S rRNA methyltransferase among aminoglycoside-resistant Klebsiella pneumoniae bloodstream isolates. Journal of Medical Microbiology, 71 (12) 001629, 1-8. doi: 10.1099/jmm.0.001629
Denholm, Justin T., Venkatesh, Balasubramanian, Davis, Joshua, Bowen, Asha C., Hammond, Naomi E., Jha, Vivekanand, McPhee, Grace, McQuilten, Zoe, O’Sullivan, Matthew V. N., Paterson, David, Price, David, Rees, Megan, Roberts, Jason, Jones, Mark, Totterdell, James, Snelling, Thomas, Trask, Nanette, Morpeth, Susan, Tong, Steven YC and on behalf of the ASCOT ADAPT investigators (2022). ASCOT ADAPT study of COVID-19 therapeutics in hospitalised patients: an international multicentre adaptive platform trial. Trials, 23 (1) 1014. doi: 10.1186/s13063-022-06929-y
Griskaitis, Matas, Furuya-Kanamori, Luis, Allel, Kasim, Stabler, Richard, Harris, Patrick, Paterson, David L. and Yakob, Laith (2022). β-lactam-resistant Streptococcus pneumoniae dynamics following treatment: a dose-response meta-analysis. Clinical Infectious Diseases, 75 (11), 1962-1970. doi: 10.1093/cid/ciac293
Aslan, Abdullah Tarık, Akova, Murat and Paterson, David L. (2022). Next-generation polymyxin class of antibiotics: a ray of hope illuminating a dark road. Antibiotics, 11 (12) 1711, 1-17. doi: 10.3390/antibiotics11121711
Lee, I. Russel, Tong, Steven Y. C., Davis, Joshua S., Paterson, David L., Syed-Omar, Sharifah F., Peck, Kwong Ran, Chung, Doo Ryeon, Cooke, Graham S., Libau, Eshele Anak, Rahman, Siti-Nabilah B. A., Gandhi, Mihir P., Shi, Luming, Zheng, Shuwei, Chaung, Jenna, Tan, Seow Yen, Kalimuddin, Shirin, Archuleta, Sophia and Lye, David C. (2022). Early oral stepdown antibiotic therapy versus continuing intravenous therapy for uncomplicated Gram-negative bacteraemia (the INVEST trial): study protocol for a multicentre, randomised controlled, open-label, phase III, non-inferiority trial. Trials, 23 (1) 572, 1-18. doi: 10.1186/s13063-022-06495-3
Tong, Steven Y. C., Mora, Jocelyn, Bowen, Asha C., Cheng, Matthew P., Daneman, Nick, Goodman, Anna L., Heriot, George S., Lee, Todd C., Lewis, Roger J., Lye, David C., Mahar, Robert K., Marsh, Julie, McGlothlin, Anna, McQuilten, Zoe, Morpeth, Susan C., Paterson, David L., Price, David J., Roberts, Jason A., Robinson, J Owen, van Hal, Sebastiaan J., Walls, Genevieve, Webb, Steve A., Whiteway, Lyn, Yahav, Dafna and Davis, Joshua S. (2022). The Staphylococcus aureus Network Adaptive Platform trial protocol: new tools for an old foe. Clinical Infectious Diseases, 75 (11), 2027-2034. doi: 10.1093/cid/ciac476
Johns, Brenton P., Dewar, David C., Loewenthal, Mark R., Manning, Laurens A., Atrey, Amit, Atri, Nipun, Campbell, David G., Dunbar, Michael, Kandel, Christopher, Khoshbin, Amir, Jones, Christopher W., Lora-Tamayo, Jaime, McDougall, Catherine, Moojen, Dirk Jan F., Mulford, Jonathan, Paterson, David L., Peel, Trisha, Solomon, Michael, Young, Simon W. and Davis, Joshua S. (2022). A desirability of outcome ranking (DOOR) for periprosthetic joint infection – a Delphi analysis. Journal of Bone and Joint Infection, 7 (6), 221-229. doi: 10.5194/jbji-7-221-2022
Laupland, Kevin B., Harris, Patrick N. A., Stewart, Adam G., Edwards, Felicity and Paterson, David L. (2022). Culture-based determinants and outcome of Staphylococcus aureus bloodstream infections. Diagnostic Microbiology and Infectious Disease, 104 (3) 115772, 1-5. doi: 10.1016/j.diagmicrobio.2022.115772
Bauer, Michelle J., Peri, Anna Maria, Lüftinger, Lukas, Beisken, Stephan, Bergh, Haakon, Forde, Brian M., Buckley, Cameron, Cuddihy, Thom, Tan, Patrice, Paterson, David L., Whiley, David M. and Harris, Patrick N. A. (2022). Optimized method for bacterial nucleic acid extraction from positive blood culture broth for whole-genome sequencing, resistance phenotype prediction, and downstream molecular applications. Journal of Clinical Microbiology, 60 (11) e01012-22, 1-11. doi: 10.1128/jcm.01012-22
Ling, Weiping, Cadavid-Restrepo, Angela, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2022). Incidence and predictors of Escherichia coli producing extended-spectrum beta-lactamase (ESBL-Ec) in Queensland, Australia from 2010 to 2019: a population-based spatial analysis. Epidemiology and Infection, 150 e178, 1-27. doi: 10.1017/s0950268822001637
Peri, Anna Maria, Ling, Weiping, Furuya-Kanamori, Luis, Harris, Patrick N. A. and Paterson, David L. (2022). Performance of BioFire Blood Culture Identification 2 Panel (BCID2) for the detection of bloodstream pathogens and their associated resistance markers: a systematic review and meta-analysis of diagnostic test accuracy studies. BMC Infectious Diseases, 22 (1) 794, 1-14. doi: 10.1186/s12879-022-07772-x
Edwards, Felicity, Glen, Kate, Harris, Patrick N. A., Paterson, David L. and Laupland, Kevin B. (2022). Determinants and outcomes of bloodstream infections related to obesity. European Journal of Clinical Microbiology and Infectious Diseases, 41 (11), 1347-1353. doi: 10.1007/s10096-022-04501-9
Stewart, Adam G., Isler, Burcu and Paterson, David L. (2022). An Australian perspective on antimicrobial stewardship programs and transplantation. Transplant Infectious Disease, 24 (5) e13912, 1-4. doi: 10.1111/tid.13912
Ranasinghe, Ama, Henderson, Andrew, Cottrell, Kyra, Tan, Cindy S. E., Burnard, Delaney, Kato, Hideo, Paterson, David L. and Harris, Patrick N. A. (2022). Determining the in vitro susceptibility of tebipenem, an oral carbapenem, against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae isolated from bloodstream infections. JAC-Antimicrobial Resistance, 4 (5) dlac105, 1-6. doi: 10.1093/jacamr/dlac105
Browning, Sarah, Manning, Laurens, Metcalf, Sarah, Paterson, David L., Robinson, James O., Clark, Benjamin and Davis, Joshua S. (2022). Characteristics and outcomes of culture-negative prosthetic joint infections from the Prosthetic Joint Infection in Australia and New Zealand Observational (PIANO) cohort study. Journal of Bone and Joint Infection, 7 (5), 203-211. doi: 10.5194/jbji-7-203-2022
Blaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381. doi: 10.1126/scitranslmed.abj238
Blaskovich, Mark A.T., Hansford, Karl A., Butler, Mark S., Ramu, Soumya, Kavanagh, Angela M., Jarrad, Angie M., Prasetyoputri, Anggia, Pitt, Miranda E., Huang, Johnny X., Lindahl, Fredrik, Ziora, Zyta M., Bradford, Tanya, Muldoon, Craig, Rajaratnam, Premraj, Pelingon, Ruby, Edwards, David J., Zhang, Bing, Amado, Maite, Elliott, Alysha G., Zuegg, Johannes, Coin, Lachlan, Woischnig, Anne-Kathrin, Khanna, Nina, Breidenstein, Elena, Stincone, Anna, Mason, Clive, Khan, Nawaz, Cho, Hye-Kyung, Karau, Melissa J. ... Cooper, Matthew A. (2022). A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections. Science Translational Medicine, 14 (662) abj2381, 1-16. doi: 10.1126/scitranslmed.abj2381
Forde, Brian M., Bergh, Haakon, Cuddihy, Thom, Hajkowicz, Krispin, Hurst, Trish, Playford, E Geoffrey, Henderson, Belinda C., Runnegar, Naomi, Clark, Julia, Jennison, Amy V., Moss, Susan, Hume, Anna, Leroux, Hugo, Beatson, Scott A., Paterson, David L. and Harris, Patrick N. A. (2022). Clinical implementation of routine whole-genome sequencing for hospital infection control of multi-drug resistant pathogens. Clinical Infectious Diseases, 76 (3), e1277-e1284. doi: 10.1093/cid/ciac726
Isler, Burcu, Vatansever, Cansel, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Stewart, Adam, Simos, Peter, Falconer, Caitlin, Bauer, Michelle J., Forde, Brian, Harris, Patrick, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Saltoğlu, Neşe ... Can, Füsun (2022). Comparison of ceftazidime-avibactam susceptibility testing methods against OXA-48-like carrying Klebsiella blood stream isolates. Diagnostic Microbiology and Infectious Disease, 104 (1) 115745, 1-4. doi: 10.1016/j.diagmicrobio.2022.115745
Hernández-Mitre, María Patricia, Tong, Steven Y. C., Denholm, Justin T., Dore, Gregory J., Bowen, Asha C., Lewin, Sharon R., Venkatesh, Balasubramanian, Hills, Thomas E., McQuilten, Zoe, Paterson, David L., Morpeth, Susan C. and Roberts, Jason A. (2022). Nafamostat mesylate for treatment of COVID-19 in hospitalised patients: a structured, narrative review. Clinical Pharmacokinetics, 61 (10), 1331-1343. doi: 10.1007/s40262-022-01170-x
Ayfan, Abdulrahman K. S., Macdonald, Joanne, Irwin, Adam D., Zowawi, Hosam M., Forde, Brian M., Paterson, David L., Lahra, Monica M. and Whiley, David M. (2022). Proof-of-concept, rapid, instrument-free molecular detection of Neisseria gonorrhoeae and ciprofloxacin susceptibility. Journal of Antimicrobial Chemotherapy, 77 (11), 2933-2936. doi: 10.1093/jac/dkac242
Isler, Burcu, Paterson, David L., Harris, Patrick N. A., Ling, Weiping, Edwards, Felicity, Rickard, Claire M., Kidd, Timothy J., Gassiep, Ian and Laupland, Kevin B. (2022). Achromobacter species: an emerging cause of community-onset bloodstream infections. Microorganisms, 10 (7) 1449, 1-9. doi: 10.3390/microorganisms10071449
Paterson, David L., Bassetti, Matteo, Motyl, Mary, Johnson, Matthew G., Castanheira, Mariana, Jensen, Erin H., Huntington, Jennifer A., Yu, Brian, Wolf, Dominik J. and Bruno, Christopher J. (2022). Ceftolozane/tazobactam for hospital-acquired/ventilator-associated bacterial pneumonia due to ESBL-producing Enterobacterales: a subgroup analysis of the ASPECT-NP clinical trial. Journal of Antimicrobial Chemotherapy, 77 (9), 2522-2531. doi: 10.1093/jac/dkac184
Peri, Anna Maria, Bauer, Michelle J., Bergh, Haakon, Butkiewicz, Dominika, Paterson, David L. and Harris, Patrick N. A. (2022). Performance of the BioFire Blood Culture Identification 2 Panel for the diagnosis of bloodstream infections. Heliyon, 8 (7) e09983, 1-6. doi: 10.1016/j.heliyon.2022.e09983
Manning, Laurens, Metcalf, Sarah, Dymock, Michael, Robinson, Owen, Clark, Benjamin, Nelson, Renjy, Paterson, David L., Yates, Piers, Loewenthal, Mark, Dewar, David, Huggan, Paul and Davis, Joshua S. (2022). Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint. International Journal of Antimicrobial Agents, 60 (1) 106598, 1-9. doi: 10.1016/j.ijantimicag.2022.106598
Ling, Weiping, Peri, Anna Maria, Furuya-Kanamori, Luis, Harris, Patrick N.A. and Paterson, David L. (2022). Carriage duration and household transmission of Enterobacterales producing extended-spectrum beta-lactamase in the community: a systematic review and meta-analysis. Microbial Drug Resistance, 28 (7), 1-11. doi: 10.1089/mdr.2022.0035
Burnard, Delaney, Bauer, Michelle J., Falconer, Caitlin, Gassiep, Ian, Norton, Robert E., Paterson, David L. and Harris, Patrick NA (2022). Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains. PLoS Neglected Tropical Diseases, 16 (6) e0009482, 1-12. doi: 10.1371/journal.pntd.0009482
Laupland, Kevin B., Paterson, David L., Stewart, Adam G., Edwards, Felicity and Harris, Patrick N. A. (2022). Sphingomonas paucimobilis bloodstream infection is a predominantly community-onset disease with significant lethality. International Journal of Infectious Diseases, 119, 172-177. doi: 10.1016/j.ijid.2022.03.060
Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G., Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Fattah, Manal Abdel, Haquin, Justine, Macgowan, Alasdair, Grier, Sally, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L., Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodríguez-Baño, Jesús, de Cueto, Marina, Oliver, Antonio, de Gopegui, Enrique Ruiz, Cano, Angela, Machuca, Isabel ... Yahav, Dafna (2022). Duration of treatment for Pseudomonas aeruginosa bacteremia: a retrospective study. Infectious Diseases and Therapy, 11 (4), 1505-1519. doi: 10.1007/s40121-022-00657-1
Falconer, Nazanin, Paterson, David L., Peel, Nancye, Welch, Alyssa, Freeman, Christopher, Burkett, Ellen, Hubbard, Ruth, Comans, Tracy, Hanjani, Leila Shafiee, Pascoe, Elaine, Hawley, Carmel and Gray, Leonard (2022). A multimodal intervention to optimise antimicrobial use in residential aged care facilities (ENGAGEMENT): protocol for a stepped-wedge cluster randomised trial. Trials, 23 (1) 427. doi: 10.1186/s13063-022-06323-8
Kwok, Michael, McGeorge, Stephen, Mayer‐Coverdale, Johanna, Graves, Bianca, Paterson, David L., Harris, Patrick N.A., Esler, Rachel, Dowling, Caroline, Britton, Sumudu and Roberts, Matthew J. (2022). Guideline of guidelines: management of recurrent urinary tract infections in women. BJU International, 11 (2), 104-107. doi: 10.1111/bju.15756
Ezure, Yukiko, Rico, Veronica, Paterson, David L., Hall, Lisa, Harris, Patrick N. A., Soriano, Alex, Roberts, Jason A., Bassetti, Matteo, Roberts, Matthew J., Righi, Elda and Wright, Hugh (2022). Efficacy and safety of carbapenems versus new antibiotics for treatment of adult patients with complicated urinary tract infections: a systematic review and meta-analysis. Open Forum Infectious Diseases, 9 (5) ofaa480, ofaa480. doi: 10.1093/ofid/ofaa480
Laupland, Kevin B., Paterson, David L., Edwards, Felicity, Stewart, Adam G. and Harris, Patrick N. A. (2022). Morganella morganii, an emerging cause of bloodstream infections. Microbiology Spectrum, 10 (3), e0056922. doi: 10.1128/spectrum.00569-22
Avent, Minyon L., McCarthy, Kate L., Sime, Fekade B., Naicker, Saiyuri, Heffernan, Aaron J., Wallis, Steven C., Paterson, David L. and Roberts, Jason A. (2022). Evaluating mono- and combination therapy of meropenem and amikacin against Pseudomonas aeruginosa bacteremia in the hollow-fiber infection model. Microbiology Spectrum, 10 (3), e0052522. doi: 10.1128/spectrum.00525-22
Schlebusch, Sanmarié, Graham, Rikki M. A., Jennison, Amy V., Lassig-Smith, Melissa M., Harris, Patrick N. A., Lipman, Jeffrey, Ó Cuív, Páraic and Paterson, David L. (2022). Standard rectal swabs as a surrogate sample for gut microbiome monitoring in intensive care. BMC Microbiology, 22 (1) 99, 1-14. doi: 10.1186/s12866-022-02487-0
Laupland, Kevin B, Stewart, Adam G, Edwards, Felicity, Paterson, David L, Coulter, Sonali, Heney, Claire, George, Narelle and Harris, Patrick (2022). Shewanella spp. bloodstream infections in Queensland, Australia. Emerging Infectious Diseases, 28 (4), 701-706. doi: 10.3201/eid2804.212193
De Oliveira, David M. P., Keller, Bernhard, Hayes, Andrew J., Ong, Cheryl-Lynn Y., Harbison-Price, Nichaela, El-Deeb, Ibrahim M., Li, Gen, Keller, Nadia, Bohlmann, Lisa, Brouwer, Stephan, Turner, Andrew G., Cork, Amanda J., Jones, Thomas R., Paterson, David L., McEwan, Alastair G., Davies, Mark R., McDevitt, Christopher A., Itzstein, Mark von and Walker, Mark J. (2022). Neurodegenerative disease treatment drug PBT2 breaks intrinsic polymyxin resistance in Gram-positive bacteria. Antibiotics, 11 (4) 449, 449. doi: 10.3390/antibiotics11040449
Isler, Burcu, Özer, Berna, Çınar, Güle, Aslan, Abdullah Tarık, Vatansever, Cansel, Falconer, Caitlin, Dolapçı, İştar, Şimşek, Funda, Tülek, Necla, Demirkaya, Hamiyet, Menekşe, Şirin, Akalin, Halis, Balkan, İlker İnanç, Aydın, Mehtap, Tigen, Elif Tükenmez, Demir, Safiye Koçulu, Kapmaz, Mahir, Keske, Şiran, Doğan, Özlem, Arabacı, Çiğdem, Yağcı, Serap, Hazırolan, Gülşen, Bakır, Veli Oğuzalp, Gönen, Mehmet, Chatfield, Mark D., Forde, Brian, Saltoğlu, Neşe, Azap, Alpay, Azap, Özlem ... Ergönül, Önder (2022). Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting. European Journal of Clinical Microbiology and Infectious Diseases, 41 (5), 841-847. doi: 10.1007/s10096-022-04425-4
Davis, Joshua S., Metcalf, Sarah, Clark, Benjamin, Owen Robinson, J., Huggan, Paul, Luey, Chris, McBride, Stephen, Aboltins, Craig, Nelson, Renjy, Campbell, David, Solomon, L. Bogdan, Schneider, Kellie, Loewenthal, Mark R., Yates, Piers, Athan, Eugene, Cooper, Darcie, Rad, Babak, Allworth, Tony, Reid, Alistair, Read, Kerry, Leung, Peter, Sud, Archana, Nagendra, Vana, Chean, Roy, Lemoh, Chris, Mutalima, Nora, Tran, Ton, Grimwade, Kate, Sehu, Marjoree ... Manning, Laurens (2022). Predictors of treatment success after periprosthetic joint infection: 24-month follow up from a Multicenter Prospective Observational Cohort Study of 653 patients. Open Forum Infectious Diseases, 9 (3) ofac048, 1-9. doi: 10.1093/ofid/ofac048
Wang, Minggui, Earley, Michelle, Chen, Liang, Hanson, Blake M., Yu, Yunsong, Liu, Zhengyin, Salcedo, Soraya, Cober, Eric, Li, Lanjuan, Kanj, Souha S., Gao, Hainv, Munita, Jose M., Ordoñez, Karen, Weston, Greg, Satlin, Michael J., Valderrama-Beltrán, Sandra L., Marimuthu, Kalisvar, Stryjewski, Martin E., Komarow, Lauren, Luterbach, Courtney, Marshall, Steve H., Rudin, Susan D., Manca, Claudia, Paterson, David L., Reyes, Jinnethe, Villegas, Maria V., Evans, Scott, Hill, Carol, Arias, Rebekka ... van Duin, David (2022). Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study. The Lancet. Infectious diseases, 22 (3), 401-412. doi: 10.1016/S1473-3099(21)00399-6
Rickard, Claire M., Paterson, David L. and Chopra, Vineet (2022). For and against routine removal of peripheral intravenous catheters. JAMA Internal Medicine, 182 (4), 456-457. doi: 10.1001/jamainternmed.2021.8304
Paterson, David L., Kinoshita, Masahiro, Baba, Takamichi, Echols, Roger and Portsmouth, Simon (2022). Outcomes with Cefiderocol treatment in patients with bacteraemia enrolled into prospective Phase 2 and Phase 3 randomised clinical studies. Infectious Diseases and Therapy, 11 (2), 853-870. doi: 10.1007/s40121-022-00598-9
Davis, Joshua S., Metcalf, Sarah, Paterson, David L., Robinson, James O., Clarke, Benjamin and Manning, Laurens (2022). Proposed empiric antibiotic therapy for prosthetic joint infections: an analysis of the Prosthetic Joint Infection in Australia and New Zealand, Observational (PIANO) cohort. Internal Medicine Journal, 52 (2), 322-325. doi: 10.1111/imj.15677
Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick, Heney, Claire, George, Narelle, Coulter, Sonali and Paterson, David L. (2022). Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019. European Journal of Clinical Microbiology and Infectious Diseases, 41 (4), 609-614. doi: 10.1007/s10096-022-04411-w
McNamara, John F, Harris, Patrick NA, Chatfield, Mark D and Paterson, David L (2022). Long term sepsis readmission, mortality and cause of death following Gram negative bloodstream infection: a propensity matched observational linkage study. International Journal of Infectious Diseases, 114, 34-44. doi: 10.1016/j.ijid.2021.10.047
Phan, Minh-Duy, Peters, Kate M., Alvarez Fraga, Laura, Wallis, Steven C., Hancock, Steven, Nhu, Nguyen Thi Khanh, Forde, Brian, Bauer, Michelle J., Paterson, David L., Beatson, Scott A, Lipman, Jeffrey and Schembri, Mark A. (2022). Plasmid-mediated ciprofloxacin resistance imparts a selective advantage on Escherichia coli ST131. Antimicrobial Agents and Chemotherapy, 66 (1) e02146-21, 1-11. doi: 10.1128/aac.02146-21
Tait, Jessica R., Bilal, Hajira, Rogers, Kate E., Lang, Yinzhi, Kim, Tae-Hwan, Zhou, Jieqiang, Wallis, Steven C., Bulitta, Jürgen B., Kirkpatrick, Carl M. J., Paterson, David L., Lipman, Jeffrey, Bergen, Phillip J., Roberts, Jason A., Nation, Roger L. and Landersdorfer, Cornelia B. (2022). Effect of different Piperacillin-Tazobactam dosage regimens on synergy of the combination with Tobramycin against Pseudomonas aeruginosa for the pharmacokinetics of critically ill patients in a dynamic infection model. Antibiotics, 11 (1) 101, 101. doi: 10.3390/antibiotics11010101
Lodise, Thomas P., Bassetti, Matteo, Ferrer, Ricard, Naas, Thierry, Niki, Yoshihito, Paterson, David L., Zeitlinger, Markus and Echols, Roger (2022). All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies. Expert Review of Anti-Infective Therapy, 20 (5), 707-719. doi: 10.1080/14787210.2022.2020099
De Oliveira, David M. P., Forde, Brian M., Phan, Minh-Duy, Steiner, Bernhard, Zhang, Bing, Zuegg, Johannes, El-deeb, Ibrahim M., Li, Gen, Keller, Nadia, Brouwer, Stephan, Harbison-Price, Nichaela, Cork, Amanda J., Bauer, Michelle J., Alquethamy, Saleh F., Beatson, Scott A., Roberts, Jason A., Paterson, David L., McEwan, Alastair G., Blaskovich, Mark A. T., Schembri, Mark A., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2022). Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection. mBio, 13 (1) e03517, e0351721. doi: 10.1128/mbio.03517-21
Peri, Anna Maria, Bauer, Michelle J., Bergh, Haakon, Butkiewicz, Dominika, Paterson, David L. and Harris, Patrick N.A. (2022). Performance of the BioFire Blood Culture Identification 2 Panel for the diagnosis of bloodstream infections on blood cultures from the intensive care unit and emergency department. SSRN Electronic Journal. doi: 10.2139/ssrn.4003859
Kwok, Michael, Yaxley, William, Ranasinghe, Sachinka, Morton, Leanne, Perera, Sachin, Ponen, Kreyen, Pelecanos, Anita, Britton, Sumudu, Harris, Patrick N. A., Paterson, David L., Esler, Rachel, Hussey, David, Yaxley, John W. and Roberts, Matthew J. (2022). Determining risk factors for symptomatic urinary tract infection following trial of void: A retrospective analysis. Journal of Clinical Urology, 205141582210998. doi: 10.1177/20514158221099856
Isler, Burcu, Aslan, Abdullah Tarık, Akova, Murat, Harris, Patrick and Paterson, David L. (2022). Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections. Expert Review of Anti-Infective Therapy, 20 (11), 1389-1400. doi: 10.1080/14787210.2022.2128764
Stewart, Adam G, Henderson, Andrew, Bauer, Michelle J, Paterson, David L and Harris, Patrick N A (2021). Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. JAC-Antimicrobial Resistance, 4 (1) dlab192, dlab192. doi: 10.1093/jacamr/dlab192
Wright, Hugh, Harris, Patrick N. A., Chatfield, Mark D., Lye, David, Henderson, Andrew, Harris-Brown, Tiffany, Donaldson, Anna and Paterson, David L. (2021). Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial. Trials, 22 (1) 889. doi: 10.1186/s13063-021-05870-w
Stewart, Adam G., Harris, Patrick N. A., Chatfield, Mark D., Littleford, Roberta and Paterson, David L. (2021). Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial. Trials, 22 (1) 301, 301. doi: 10.1186/s13063-021-05206-8
Henderson, Andrew, Bursle, Evan, Stewart, Adam, Harris, Patrick N. A., Paterson, David, Chatfield, Mark D., Paul, Mical, Dickstein, Yaakov, Rodriguez-Baño, Jesus, Turnidge, John D. and Kahlmeter, Gunnar (2021). A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. Clinical Microbiology and Infection, 27 (12), 1746-1753. doi: 10.1016/j.cmi.2021.03.019
Axfors, Cathrine, Janiaud, Perrine, Schmitt, Andreas M., van’t Hooft, Janneke, Smith, Emily R., Haber, Noah A., Abayomi, Akin, Abduljalil, Manal, Abdulrahman, Abdulkarim, Acosta-Ampudia, Yeny, Aguilar-Guisado, Manuela, Al-Beidh, Farah, Alejandria, Marissa M., Alfonso, Rachelle N., Ali, Mohammad, AlQahtani, Manaf, AlZamrooni, Alaa, Anaya, Juan-Manuel, Ang, Mark Angelo C., Aomar, Ismael F., Argumanis, Luis E., Averyanov, Alexander, Baklaushev, Vladimir P., Balionis, Olga, Benfield, Thomas, Berry, Scott, Birocco, Nadia, Bonifacio, Lynn B., Bowen, Asha C. ... Hemkens, Lars G. (2021). Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials. BMC Infectious Diseases, 21 (1) 1170, 1170. doi: 10.1186/s12879-021-06829-7
Paterson, David L. and Rickard, Claire M. (2021). Letter from Australia: a never-ending pandemic?. Annals of Internal Medicine, 174 (12), 1743-1744. doi: 10.7326/m21-3295
Peri, Anna Maria, Harris, Patrick N. A. and Paterson, David L. (2021). Culture-independent detection systems for bloodstream infection. Clinical Microbiology and Infection, 28 (2), 195-201. doi: 10.1016/j.cmi.2021.09.039
Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2021). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response. Journal of Antimicrobial Chemotherapy, 76 (12), 3327-3328. doi: 10.1093/jac/dkab366
Ling, Weiping, Furuya-Kanamori, Luis, Ezure, Yukiko, Harris, Patrick N. A. and Paterson, David L. (2021). Adverse clinical outcomes associated with carbapenem-resistant Acinetobacter (CRA) infections: a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 3 (4) dlab157, 1-12. doi: 10.1093/jacamr/dlab157
Wen, Sophie C. H., Ezure, Yukiko, Rolley, Lauren, Spurling, Geoff, Lau, Colleen L., Riaz, Saba, Paterson, David L. and Irwin, Adam D. (2021). Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis. PLoS Medicine, 18 (9) e1003787, 1-20. doi: 10.1371/journal.pmed.1003787
Billot, Laurent, Lipman, Jeffrey, Brett, Stephen J., Waele, Jan J. De, Cotta, Menino Osbert, Davis, Joshua S., Finfer, Simon, Hammond, Naomi E., Knowles, Serena, McGuinness, Shay, Myburgh, John, Paterson, David L., Peake, Sandra, Rajbhandari, Dorrilyn, Rhodes, Andrew, Roger, Claire, Roberts, Jason A., Shirwadkar, Charudatt, Starr, Therese, Taylor, Colman, Dulhunty, Joel M. and For the BLING III Investigators (2021). Statistical analysis plan for the BLING III study: a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis. Critical Care and Resuscitation, 23 (3), 273-284. doi: 10.51893/2021.3.oa4
Russo, Alessandro, Paterson, David L. and Bassetti, Matteo (2021). Editorial: spotlight on the relationship between sepsis and infection: from mechanisms to therapy. Frontiers in Medicine, 8 716215, 716215. doi: 10.3389/fmed.2021.716215
Stewart, Adam G., Paterson, David L., Young, Barnaby, Lye, David C, Davis, Joshua S., Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M., Chatfield, Mark D., Bauer, Michelle J., Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N. A. and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2021). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2). Open Forum Infectious Diseases, 8 (8) ofab387, ofab387. doi: 10.1093/ofid/ofab387
Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G, Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Abdel Fattah, Manal, Haquin, Justine, MacGowan, Alasdair, Grier, Sally, Gibbs, Julie, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L, Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodriguez-Bano, Jesus, Morales, Isabel, Oliver, Antonio, Ruiz De Gopegui, Enrique, Cano, Angela ... Yahav, Dafna (2021). Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study. Journal of Antimicrobial Chemotherapy, 76 (8), 2172-2181. doi: 10.1093/jac/dkab134
Arabi, Yaseen M., Gordon, Anthony C., Derde, Lennie P. G., Nichol, Alistair D., Murthy, Srinivas, Beidh, Farah Al, Annane, Djillali, Swaidan, Lolowa Al, Beane, Abi, Beasley, Richard, Berry, Lindsay R., Bhimani, Zahra, Bonten, Marc J. M., Bradbury, Charlotte A., Brunkhorst, Frank M., Buxton, Meredith, Buzgau, Adrian, Cheng, Allen, De Jong, Menno, Detry, Michelle A., Duffy, Eamon J., Estcourt, Lise J., Fitzgerald, Mark, Fowler, Rob, Girard, Timothy D., Goligher, Ewan C., Goossens, Herman, Haniffa, Rashan, Higgins, Alisa M. ... on behalf of the REMAP-CAP Investigators (2021). Lopinavir-ritonavir and hydroxychloroquine for critically ill patients with COVID-19: REMAP-CAP randomized controlled trial. Intensive Care Medicine, 47 (8), 867-886. doi: 10.1007/s00134-021-06448-5
Huber, Charlotte A., Reed, Sarah J. and Paterson, David L. (2021). Bacterial sub-species typing using matrix-assisted laser desorption/ionization time of flight mass spectrometry: what is promising?. Current Issues in Molecular Biology, 43 (2), 749-757. doi: 10.3390/cimb43020054
McCarthy, K. L., Harris-Brown, T., Smits, E. J., Legg, A., Chatfield, M. D. and Paterson, D. L. (2021). The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial. European Journal of Clinical Microbiology & Infectious Diseases, 40 (12), 2505-2513. doi: 10.1007/s10096-021-04294-3
Stewart, Adam G., Cottrell, Kyra, Henderson, Andrew, Vemuri, Kanthi, Bauer, Michelle J., Paterson, David L. and Harris, Patrick N. A. (2021). In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO Trial. Microbiology Spectrum, 9 (1) e00226-21, 1-6. doi: 10.1128/spectrum.00226-21
Murigneux, Valentine, Roberts, Leah W., Forde, Brian M., Phan, Minh-Duy, Nhu, Nguyen Thi Khanh, Irwin, Adam D., Harris, Patrick N. A., Paterson, David L., Schembri, Mark A., Whiley, David M. and Beatson, Scott A. (2021). MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction. BMC Genomics, 22 (1) 474, 474. doi: 10.1186/s12864-021-07767-z
Irwin, Adam D., Coin, Lachlan J. M., Harris, Patrick N. A., Cotta, Menino Osbert, Bauer, Michelle J., Buckley, Cameron, Balch, Ross, Kruger, Peter, Meyer, Jason, Shekar, Kiran, Brady, Kara, Fourie, Cheryl, Sharp, Natalie, Vlad, Luminita, Whiley, David, Beatson, Scott A., Forde, Brian M., Paterson, David, Clark, Julia, Hajkowicz, Krispin, Raman, Sainath, Bialasiewicz, Seweryn, Lipman, Jeffrey, Schlapbach, Luregn J. and Roberts, Jason A. (2021). Optimising treatment outcomes for children and adults through rapid genome sequencing of sepsis pathogens. A study protocol for a prospective, multi-centre trial (DIRECT). Frontiers in Cellular and Infection Microbiology, 11 667680, 1-8. doi: 10.3389/fcimb.2021.667680
Stewart, Adam G., Satlin, Michael J., Schlebusch, Sanmarié, Isler, Burcu, Forde, Brian M., Paterson, David L. and Harris, Patrick N. A. (2021). Completing the picture - capturing the resistome in antibiotic clinical trials. Clinical Infectious Diseases, 72 (12), e1122-e1129. doi: 10.1093/cid/ciaa1877
Fang, Ferric C., Benson, Constance A., Del Rio, Carlos, Edwards, Kathryn M., Fowler, Vance G., Fredricks, David N., Limaye, Ajit P., Murray, Barbara E., Naggie, Susanna, Pappas, Peter G., Patel, Robin, Paterson, David L., Pegues, David A., Petri, William A. and Schooley, Robert T. (2021). COVID-19-lessons learned and questions remaining. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72 (12), 2225-2240. doi: 10.1093/cid/ciaa1654
Foster, Andrew L., Cutbush, Kenneth, Ezure, Yukiko, Schuetz, Michael A., Crawford, Ross and Paterson, David L. (2021). Cutibacterium acnes in shoulder surgery: a scoping review of strategies for prevention, diagnosis, and treatment. Journal of Shoulder and Elbow Surgery, 30 (6), 1410-1422. doi: 10.1016/j.jse.2020.11.011
Ayfan, Abdulrahman K. S., Macdonald, Joanne, Harris, Patrick N. A., Heney, Claire, Paterson, David L., Trembizki, Ella, Wang, Claire Y. T., Whiley, David M., Zowawi, Hosam M. and Irwin, Adam D. (2021). Rapid detection of NDM and VIM carbapenemase encoding genes by recombinase polymerase amplification and lateral flow–based detection. European Journal of Clinical Microbiology & Infectious Diseases, 40 (11), 2447-2453. doi: 10.1007/s10096-021-04267-6
Abdul Rahim, Nusaibah, Zhu, Yan, Cheah, Soon-Ee, Johnson, Matthew D., Yu, Heidi H., Sidjabat, Hanna E., Butler, Mark S., Cooper, Matthew A., Fu, Jing, Paterson, David L., Nation, Roger L., Boyce, John D., Creek, Darren J., Bergen, Phillip J., Velkov, Tony and Li, Jian (2021). Synergy of the polymyxin-chloramphenicol combination against New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae is predominately driven by chloramphenicol. ACS Infectious Diseases, 7 (6), 1584-1595. doi: 10.1021/acsinfecdis.0c00661
Ling, Weiping, Furuya-Kanamori, Luis, Ezure, Yukiko, Harris, Patrick N A and Paterson, David L (2021). Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): a systematic review and meta-analysis. JAC-Antimicrobial Resistance, 3 (2) dlab068, dlab068. doi: 10.1093/jacamr/dlab068
Agyeman, Akosua A., Rogers, Kate E., Tait, Jessica R., Bergen, Phillip J., Kirkpatrick, Carl M., Wallis, Steven C., Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2021). Evaluation of meropenem-ciprofloxacin combination dosage regimens for the pharmacokinetics of critically ill patients with augmented renal clearance. Clinical Pharmacology and Therapeutics, 109 (4), 1104-1115. doi: 10.1002/cpt.2191
Koulenti, Despoina, Armaganidis, Apostolos, Arvaniti, Kostoula, Blot, Stijn, Brun-Buisson, Christian, Deja, Maria, De Waele, Jan, Du, Bin, Dulhunty, Joel M., Garcia-Diaz, Julia, Judd, Matthew, Paterson, David L., Putensen, Christian, Reina, Rosa, Rello, Jordi, Restrepo, Marcos I., Roberts, Jason A., Sjovall, Fredrik, Timsit, Jean-Francois, Tsiodras, Sotirios, Zahar, Jean-Ralph, Zhang, Yuchi, Lipman, Jeffrey and On behalf of the Working Group on Pneumonia of the European Society of Intensive Care Medicine (2021). Protocol for an international, multicentre, prospective, observational study of nosocomial pneumonia in intensive care units: The PneumoINSPIRE study. Critical Care and Resuscitation, 23 (1), 59-66. doi: 10.51893/2021.1.oa5
Roberts, Leah W., Forde, Brian M., Hurst, Trish, Ling, Weiping, Nimmo, Graeme R., Bergh, Haakon, George, Narelle, Hajkowicz, Krispin, McNamara, John F., Lipman, Jeffrey, Permana, Budi, Schembri, Mark A., Paterson, David, Beatson, Scott A. and Harris, Patrick N. A. (2021). Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care. Microbial Genomics, 7 (3) 000530. doi: 10.1099/mgen.0.000530
Burnard, Delaney, Robertson, Gemma, Henderson, Andrew, Falconer, Caitlin, Bauer, Michelle J., Cottrell, Kyra, Gassiep, Ian, Norton, Robert, Paterson, David L. and Harris, Patrick N. A. (2021). Burkholderia pseudomallei clinical isolates are highly susceptible in vitro to cefiderocol, a siderophore cephalosporin. Antimicrobial Agents and Chemotherapy, 65 (2) e00685-20. doi: 10.1128/aac.00685-20
Bassetti, Matteo, Echols, Roger, Matsunaga, Yuko, Ariyasu, Mari, Doi, Yohei, Ferrer, Ricard, Lodise, Thomas P., Naas, Thierry, Niki, Yoshihito, Paterson, David L., Portsmouth, Simon, Torre-Cisneros, Julian, Toyoizumi, Kiichiro, Wunderink, Richard G. and Nagata, Tsutae D. (2021). Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. The Lancet Infectious Diseases, 21 (2), 226-240. doi: 10.1016/S1473-3099(20)30796-9
Kato, Hideo, Parker, Suzanne L., Roberts, Jason A., Hagihara, Mao, Asai, Nobuhiro, Yamagishi, Yuka, Paterson, David L. and Mikamo, Hiroshige (2021). Population pharmacokinetics analysis of amikacin initial dosing regimen in elderly patients. Antibiotics, 10 (2) 100, 1-13. doi: 10.3390/antibiotics10020100
Paterson, David L., Isler, Burcu and Harris, Patrick N. A. (2021). PRO: Carbapenems should be used for ALL infections caused by ceftriaxone-resistant Enterobacterales. JAC-Antimicrobial Resistance, 3 (1). doi: 10.1093/jacamr/dlab013
Stewart, Adam G. and Paterson, David L. (2021). How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy, 22 (14), 1-14. doi: 10.1080/14656566.2021.1935868
Wen, Sophie C.H., Ezure, Yukiko, Rolley, Lauren, Spurling, Geoff, Lau, Colleen L., Paterson, David L. and Irwin, Adam D. (2021). Gram-Negative Neonatal Sepsis in Low- and Middle- Income Countries: How Appropriate are the WHO Recommended Empirical Sepsis Antibiotic Regimens? A Systematic Review and Meta-Analysis. SSRN Electronic Journal. doi: 10.2139/ssrn.3777180
Elliott, Thomas M., Harris, Patrick N., Roberts, Leah W., Doidge, Michelle, Hurst, Trish, Hajkowicz, Krispin, Forde, Brian, Paterson, David L. and Gordon, Louisa G. (2021). Cost-effectiveness analysis of whole-genome sequencing during an outbreak of carbapenem-resistant Acinetobacter baumannii. Antimicrobial Stewardship and Healthcare Epidemiology, 1 (1) e62, e62. doi: 10.1017/ash.2021.233
Isler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of Antimicrobial Chemotherapy, 76 (3), 550-560. doi: 10.1093/jac/dkaa511
van Duin, David and Paterson, David L. (2020). Multidrug-Resistant Bacteria in the Community: An Update. Infectious Disease Clinics of North America, 34 (4), 709-722. doi: 10.1016/j.idc.2020.08.002
Gordon, Louisa G., Elliott, Thomas M., Forde, Brian, Mitchell, Brett, Russo, Philip L., Paterson, David L. and Harris, Patrick N. A. (2020). Budget impact analysis of routinely using whole-genomic sequencing of six multidrug-resistant bacterial pathogens in Queensland, Australia. BMJ Open, 11 (2) e041968, e041968. doi: 10.1136/bmjopen-2020-041968
De Oliveira, David M. P., Bohlmann, Lisa, Conroy, Trent, Jen, Freda E.-C., Everest-Dass, Arun, Hansford, Karl A., Bolisetti, Raghu, El-Deeb, Ibrahim M., Forde, Brian M., Phan, Minh-Duy, Lacey, Jake A., Tan, Aimee, Rivera-Hernandez, Tania, Brouwer, Stephan, Keller, Nadia, Kidd, Timothy J., Cork, Amanda J., Bauer, Michelle J., Cook, Gregory M., Davies, Mark R., Beatson, Scott A., Paterson, David L., McEwan, Alastair G., Li, Jian, Schembri, Mark A., Blaskovich, Mark A. T., Jennings, Michael P., McDevitt, Christopher A., von Itzstein, Mark and Walker, Mark J. (2020). Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis. Science Translational Medicine, 12 (570) abb3791, eabb3791. doi: 10.1126/scitranslmed.abb3791
Isler, Burcu, Kidd, Timothy J., Stewart, Adam G., Harris, Patrick and Paterson, David L. (2020). Achromobacter infections and treatment options. Antimicrobial Agents and Chemotherapy, 64 (11) e01025, 1-16. doi: 10.1128/aac.01025-20
Henderson, A., Paterson, D. L., Chatfield, M. D., Tambyah, P. A., Lye, D. C., De, P. P., Lin, R. T. P., Chew, K. L., Yin, M., Lee, T. H., Yilmaz, M., Cakmak, R., Alenazi, T. H., Arabi, Y. M., Falcone, M., Bassetti, M., Righi, E., Rogers, B.A., Kanj, S. S., Bhally, H., Iredell, J., Mendelson, M., Boyles, T. H., Looke, D. F. M., Runnegar, N. J., Miyakis, S., Walls, G., AI Khamis, M., Zikri, A. ... For the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2020). Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study. Clinical Infectious Diseases, 73 (11), e3842-e3850. doi: 10.1093/cid/ciaa1479
Isler, Burcu, Ezure, Yukiko, García-Fogeda Romero, Jose Luis, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). Is ceftazidime/avibactam an option for serious infections due to ESBL and AmpC producing Enterobacterales?: a systematic review and meta-analysis. Antimicrobial Agents and Chemotherapy, 65 (1) e01052-20. doi: 10.1128/AAC.01052-20
McNamara, John F., Harris, Patrick N. A., Chatfield, Mark D. and Paterson, David L. (2020). Reply to Rezahosseini and Nielsen. Clinical Infectious Diseases, 72 (11), e916-e916. doi: 10.1093/cid/ciaa1449
Burnard, Delaney, Gore, Letitia, Henderson, Andrew, Ranasinghe, Ama, Bergh, Haakon, Cottrell, Kyra, Sarovich, Derek S., Price, Erin P., Paterson, David L. and Harris, Patrick N. A. (2020). Comparative genomics and antimicrobial resistance profiling of Elizabethkingia isolates reveals nosocomial transmission and in vitro susceptibility to fluoroquinolones, tetracyclines and trimethoprim-sulfamethoxazole. Journal of Clinical Microbiology, 58 (9) e00730-20. doi: 10.1128/jcm.00730-20
Hancock, Steven J., Phan, Minh-Duy, Luo, Zhenyao, Lo, Alvin W., Peters, Kate M., Nhu, Nguyen Thi Khanh, Forde, Brian M., Whitfield, Jason, Yang, Ji, Strugnell, Richard A., Paterson, David L., Walsh, Timothy R., Kobe, Bostjan, Beatson, Scott A. and Schembri, Mark A. (2020). Comprehensive analysis of IncC plasmid conjugation identifies a crucial role for the transcriptional regulator AcaB. Nature Microbiology, 5 (11), 1340-1348. doi: 10.1038/s41564-020-0775-0
McNamara, John F., Harris, Patrick N. A., Chatfield, Mark D. and Paterson, David L. (2020). Acute myocardial infarction and community-acquired Staphylococcus aureus bloodstream infection: an observational cohort study. Clinical Infectious Diseases, 73 (9), e2647-e2655. doi: 10.1093/cid/ciaa1197
Forde, Brian M., Henderson, Andrew, Playford, Elliott G., Looke, David, Henderson, Belinda C., Watson, Catherine, Steen, Jason A., Sidjabat, Hanna E., Laurie, Gordon, Muttaiyah, Sharmini, Nimmo, Graeme R., Lampe, Guy, Smith, Helen, Jennison, Amy V., McCall, Brad, Carroll, Heidi, Cooper, Matthew A., Paterson, David L. and Beatson, Scott A. (2020). Fatal respiratory diphtheria caused by ß-lactam–resistant corynebacterium diphtheriae. Clinical Infectious Diseases, 73 (11), e4531-e4538. doi: 10.1093/cid/ciaa1147
Roberts, Matthew J., Macdonald, Alastair, Ranasinghe, Sachinka, Bennett, Harrison, Teloken, Patrick E., Harris, Patrick, Paterson, David, Coughlin, Geoff, Dunglison, Nigel, Esler, Rachel, Gardiner, Robert A., Elliott, Thomas, Gordon, Louisa and Yaxley, John (2020). Transrectal versus transperineal prostate biopsy under intravenous anaesthesia: a clinical, microbiological and cost analysis of 2048 cases over 11 years at a tertiary institution. Prostate Cancer and Prostatic Diseases, 24 (1), 169-176. doi: 10.1038/s41391-020-0263-x
Abdul Rahim, Nusaibah, Cheah, Soon-Ee, Johnson, Matthew D., Zhu, Yan, Yu, Heidi H., Sidjabat, Hanna E., Butler, Mark S., Cooper, Matthew A., Fu, Jing, Paterson, David L., Nation, Roger L., Boyce, John D., Bergen, Phillip J., Velkov, Tony and Li, Jian (2020). Transcriptomic responses of a New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae isolate to the combination of polymyxin B and chloramphenicol. International Journal of Antimicrobial Agents, 56 (2) 106061, 106061. doi: 10.1016/j.ijantimicag.2020.106061
Zeitlinger, Markus, Koch, Birgit C. P., Bruggemann, Roger, De Cock, Pieter, Felton, Timothy, Hites, Maya, Le, Jennifer, Luque, Sonia, MacGowan, Alasdair P., Marriott, Deborah J. E., Muller, Anouk E., Nadrah, Kristina, Paterson, David L., Standing, Joseph F., Telles, João P., Wölfl-Duchek, Michael, Thy, Michael and Roberts, Jason A. (2020). Pharmacokinetics/pharmacodynamics of antiviral agents used to treat SARS-CoV-2 and their potential interaction with drugs and other supportive measures: a comprehensive review by the PK/PD of anti-infectives study group of the European Society of Antimicrobial Agents. Clinical Pharmacokinetics, 59 (10), 1195-1216. doi: 10.1007/s40262-020-00924-9
Denholm, Justin T., Davis, Joshua, Paterson, David, Roberts, Jason, Morpeth, Susan, Snelling, Thomas, Zentner, Dominica, Rees, Megan, O'Sullivan, Matthew, Price, David, Bowen, Asha, Tong, Steven Y. C., Davis, Joshua, Denholm, Justin, Tong, Steven, ASCOT Investigator Group, Rees, Megan, Paterson, David, Price, David, Morpeth, Susan, O'Sullivan, Matthew, Roberts, Jason, Snelling, Thomas, Anderson, Sue, McQuilton, Zoe, Venkatesh, Bala, Hammond, Naomi, Jha, Vivekanend, Burston, Victoria John ... Slow, Sandy (2020). The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial. Trials, 21 (1) 646. doi: 10.1186/s13063-020-04576-9
De Oliveira, David M. P., Forde, Brian M., Kidd, Timothy J., Harris, Patrick N. A., Schembri, Mark A., Beatson, Scott A., Paterson, David L. and Walker, Mark J. (2020). Antimicrobial resistance in ESKAPE pathogens. Clinical Microbiology Reviews, 33 (3) e00181-19, e00181-19. doi: 10.1128/cmr.00181-19
van Duin, David, Arias, Cesar A., Komarow, Lauren, Chen, Liang, Hanson, Blake M., Weston, Gregory, Cober, Eric, Garner, Omai B., Jacob, Jesse T., Satlin, Michael J., Fries, Bettina C., Garcia-Diaz, Julia, Doi, Yohei, Dhar, Sorabh, Kaye, Keith S., Earley, Michelle, Hujer, Andrea M., Hujer, Kristine M., Domitrovic, T. Nicholas, Shropshire, William C., An Dinh, , Manca, Claudia, Luterbach, Courtney L., Wang, Minggui, Paterson, David L., Banerjee, Ritu, Patel, Robin, Evans, Scott, Hill, Carol ... Bonomo, Robert A. (2020). Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study. Lancet Infectious Diseases, 20 (6), 731-741. doi: 10.1016/S1473-3099(19)30755-8
Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G., Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Abdel Fattah, Manal, Haquin, Justine, Macgowan, Alasdair, Grier, Sally, Gibbs, Julie, Chazan, Bibiana, Yanovskay, Anna, Ben Ami, Ronen, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L., Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodriguez-Bano, Jesus, Morales, Isabel, Oliver, Antonio, Ruiz De Gopegui, Enrique, Cano, Angela ... Yahav, Dafna (2020). Ceftazidime, carbapenems, or piperacillin-tazobactam as single definitive therapy for Pseudomonas aeruginosa bloodstream infection: a multisite retrospective study. Clinical Infectious Diseases, 70 (11), 2270-2280. doi: 10.1093/cid/ciz668
Stewart, Adam G., Harris, Patrick N. A., Henderson, Andrew, Schembri, Mark A. and Paterson, David L. (2020). Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections. Journal of Antimicrobial Chemotherapy, 75 (9), 2384-2393. doi: 10.1093/jac/dkaa183
Manning, Laurens, Metcalf, Sarah, Clark, Benjamin, Robinson, James Owen, Huggan, Paul, Luey, Chris, McBride, Stephen, Aboltins, Craig, Nelson, Renjy, Campbell, David, Solomon, Lucian Bogdan, Schneider, Kellie, Loewenthal, Mark, Yates, Piers, Athan, Eugene, Cooper, Darcie, Rad, Babak, Allworth, Tony, Reid, Alistair, Read, Kerry, Leung, Peter, Sud, Archana, Nagendra, Vana, Chean, Roy, Lemoh, Chris, Mutalima, Nora, Grimwade, Kate, Sehu, Marjorie, Torda, Adrienne ... Davis, Josh (2020). Clinical characteristics, etiology, and initial management strategy of newly diagnosed periprosthetic joint infection: a multicenter, prospective observational cohort study of 783 patients. Open Forum Infectious Diseases, 7 (5) ofaa068, 1-10. doi: 10.1093/ofid/ofaa068
Chapman, Paul, Forde, Brian M., Roberts, Leah W., Bergh, Haakon, Vesey, Debra, Jennison, Amy V., Moss, Susan, Paterson, David L., Beatson, Scott A. and Harris, Patrick N. A. (2020). Genomic investigation reveals contaminated detergent as the source of an Extended-Spectrum-β-Lactamase-producing Klebsiella michiganensis outbreak in a neonatal unit. Journal of Clinical Microbiology, 58 (5) e01980. doi: 10.1128/jcm.01980-19
Shen, Cong, Zhong, Lan-Lan, Yang, Yongqiang, Doi, Yohei, Paterson, David L., Stoesser, Nicole, Ma, Furong, El-Sayed Ahmed, Mohamed Abd El-Gawad, Feng, Siyuan, Huang, Songyin, Li, Hong-Yu, Huang, Xi, Wen, Xin, Zhao, Zihan, Lin, Minmin, Chen, Guanping, Liang, Wanfei, Liang, Yingjian, Xia, Yong, Dai, Min, Chen, Ding-Qiang, Zhang, Liyan, Liao, Kang and Tian, Guo-Bao (2020). Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological study. The Lancet Microbe, 1 (1), e34-e43. doi: 10.1016/S2666-5247(20)30005-7
Paterson, David L., Isler, Burcu and Stewart, Adam (2020). New treatment options for multiresistant gram negatives. Current Opinion in Infectious Diseases, 33 (2), 214-223. doi: 10.1097/QCO.0000000000000627
Butler, Mark S. and Paterson, David L. (2020). Antibiotics in the clinical pipeline in October 2019. The Journal of Antibiotics, 73 (6), 329-364. doi: 10.1038/s41429-020-0291-8
Foster, Andrew L., Moriarty, T. Fintan, Trampuz, Andrej, Jaiprakash, Anjali, Burch, Marc A., Crawford, Ross, Paterson, David L., Metsemakers, Willem-Jan, Schuetz, Michael and Richards, R. Geoff (2020). Fracture-related infection: current methods for prevention and treatment. Expert Review of Anti-Infective Therapy, 18 (4), 1-15. doi: 10.1080/14787210.2020.1729740
Tong, Steven Y. C., Lye, David C., Yahav, Dafna, Sud, Archana, Robinson, J. Owen, Nelson, Jane, Archuleta, Sophia, Roberts, Matthew A., Cass, Alan, Paterson, David L., Foo, Hong, Paul, Mical, Guy, Stephen D., Tramontana, Adrian R., Walls, Genevieve B., McBride, Stephen, Bak, Narin, Ghosh, Niladri, Rogers, Benjamin A., Ralph, Anna P., Davies, Jane, Ferguson, Patricia E., Dotel, Ravindra, McKew, Genevieve L., Gray, Timothy J., Holmes, Natasha E., Smith, Simon, Warner, Morgyn S., Kalimuddin, Shirin ... Davis, Joshua S. (2020). Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial. JAMA - Journal of the American Medical Association, 323 (6), 527-537. doi: 10.1001/jama.2020.0103
Paterson, David L., Henderson, Andrew and Harris, Patrick N. A. (2020). Current evidence for therapy of ceftriaxone-resistant Gram-negative bacteremia. Current Opinion in Infectious Diseases, 33 (1), 78-85. doi: 10.1097/QCO.0000000000000623
McNamara, J. F., Harris, P. N. A., Chatfield, M. D., Lorenc, P. and Paterson, D. L. (2020). Measuring patient-centred long-term outcome following a bloodstream infection: a pilot study. Clinical Microbiology and Infection, 26 (2), 257.e1-257.e4. doi: 10.1016/j.cmi.2019.10.011
Babich, Tanya, Naucler, Pontus, Valik, John Karlsson, Giske, Christian G., Benito, Natividad, Cardona, Ruben, Rivera, Alba, Pulcini, Celine, Fattah, Manal Abdel, Haquin, Justine, MacGowan, Alasdair, Grier, Sally, Chazan, Bibiana, Yanovskay, Anna, Ami, Ronen Ben, Landes, Michal, Nesher, Lior, Zaidman-Shimshovitz, Adi, McCarthy, Kate, Paterson, David L., Tacconelli, Evelina, Buhl, Michael, Mauer, Susanna, Rodriguez-Bano, Jesus, Morales, Isabel, Oliver, Antonio, de Gopegui, Enrique Ruiz, Cano, Angela, Machuca, Isabel ... Yahav, Dafna (2020). Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study. International Journal of Antimicrobial Agents, 55 (2) 105847, 105847. doi: 10.1016/j.ijantimicag.2019.11.004
McNamara, John F., Avent, Minyon, Stewart, Adam, Kwan, Christopher and Paterson, David L. (2020). Evaluation of quick sequential organ failure assessment and systemic inflammatory response syndrome in patients with gram negative bloodstream infection. Infection, Disease and Health, 25 (3), 151-157. doi: 10.1016/j.idh.2020.01.003
Roberts, Leah W., Harris, Patrick N. A., Forde, Brian M., Ben Zakour, Nouri L., Catchpoole, Elizabeth, Stanton-Cook, Mitchell, Phan, Minh-Duy, Sidjabat, Hanna E., Bergh, Haakon, Heney, Claire, Gawthorne, Jayde A., Lipman, Jeffrey, Allworth, Anthony, Chan, Kok-Gan, Chong, Teik Min, Yin, Wai-Fong, Schembri, Mark A., Paterson, David L. and Beatson, Scott A. (2020). Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei. Nature Communications, 11 (1) 466, 466. doi: 10.1038/s41467-019-14139-5
Lee, Xing J., Elliott, Thomas M., Harris, Patrick N. A., Douglas, Joel, Henderson, Belinda, Watson, Catherine, Paterson, David L., Schofield, Deborah S., Graves, Nicholas and Gordon, Louisa G. (2020). Clinical and Economic Outcomes of Genome Sequencing Availability on Containing a Hospital Outbreak of Resistant Escherichia coli in Australia. Value in Health, 23 (8), 994-1002. doi: 10.1016/j.jval.2020.03.006
Yadav, Rajbharan, Bergen, Phillip J., Rogers, Kate E., Kirkpatrick, Carl M. J., Wallis, Steven C., Huang, Yuling, Bulitta, Jürgen B., Paterson, David L., Lipman, Jeffrey, Nation, Roger L., Roberts, Jason A. and Landersdorfer, Cornelia B. (2020). Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients. Antimicrobial Agents and Chemotherapy, 64 (1) e01679-19. doi: 10.1128/aac.01679-19
Roberts, Leah W., Catchpoole, Elizabeth, Jennison, Amy V., Bergh, Haakon, Hume, Anna, Heney, Claire, George, Narelle, Paterson, David L., Schembri, Mark A., Beatson, Scott A. and Harris, Patrick N. A. (2019). Genomic analysis of carbapenemase-producing Enterobacteriaceae in Queensland reveals widespread transmission of blaIMP-4 on an IncHI2 plasmid. Microbial Genomics, 6 (1) 000321. doi: 10.1099/mgen.0.000321
Stewart, Adam G, Harris, Patrick N A, Chatfield, Mark, Evans, Scott R, van Duin, David and Paterson, David L (2019). Modern clinician-initiated clinical trials to determine optimal therapy for multi-drug resistant Gram-negative infections. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 71 (2), 433-439. doi: 10.1093/cid/ciz1132
Peel, Trisha, Astbury, Sarah, Cheng, Allen C., Paterson, David, Buising, Kirsty, Spelman, Tim, Tran-Duy, An and de Steiger, Richard S. (2019). Multicentre randomised double-blind placebo controlled trial of combination vancomycin and cefazolin surgical antibiotic prophylaxis: the Australian surgical antibiotic prophylaxis (ASAP) trial. BMJ Open, 9 (11) 033718, e033718. doi: 10.1136/bmjopen-2019-033718
Machuca, Isabel, Gutiérrez-Gutiérrez, Belén, Rivera-Espinar, Francisco, Cano, Angela, Gracia-Ahufinger, I., Guzman-Puche, J., Marfil-Pérez, Eduardo, Pérez-Nadales, E., Castón, Juan José, Bonomo, Robert A., Carmeli, Yehuda, Paterson, D., Pascual, Álvaro, Martínez-Martínez, Luís, Rodríguez-Baño, Jesús and Torre-Cisneros, Julián (2019). External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteraemia cohort: the prognostic significance of colistin resistance. International Journal of Antimicrobial Agents, 54 (4), 442-448. doi: 10.1016/j.ijantimicag.2019.07.017
Marimuthu, Kalisvar, Ng, Oon Tek, Cherng, Benjamin Pei Zhi, Fong, Raymond Kok Choon, Pada, Surinder Kaur, De, Partha Pratim, Ooi, Say Tat, Smitasin, Nares, Thoon, Koh Cheng, Krishnan, Prabha Unny, Ang, Michelle Lay Teng, Chan, Douglas Su Gin, Kwa, Andrea Lay Hoon, Deepak, Rama Narayana, Chan, Yu Kit, Chan, Yvonne Fu Zi, Huan, Xiaowei, Linn, Kyaw Zaw, Tee, Nancy Wen Sim, Tan, Thean Yen, Koh, Tse Hsien, Lin, Raymond Tzer Pin, Hsu, Li Yang, Sengupta, Sharmila, Paterson, David L., Perencevich, Eli, Harbarth, Stephan, Teo, Jeanette, Venkatachalam, Indumathi ... Cheng, Thoon Koh (2019). Antecedent carbapenem exposure as a risk factor for non-carbapenemase-producing carbapenem-resistant Enterobacteriaceae and carbapenemase-producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 63 (10) e00845-19. doi: 10.1128/AAC.00845-19
Henderson, A., Harris, P., Hartel, G., Paterson, D., Turnidge, J., Davis, J. S. and Tong, S. Y. C. (2019). Benzylpenicillin versus flucloxacillin for penicillin susceptible Staphylococcus aureus bloodstream infections from a large retrospective cohort study. International Journal of Antimicrobial Agents, 54 (4), 491-495. doi: 10.1016/j.ijantimicag.2019.05.020
Huber, Charlotte A, Pflüger, Valentin, Reed, Sarah, Cottrell, Kyra, Sidjabat, Hanna E, Ranasinghe, Ama, Zowawi, Hosam, Harris, Patrick and Paterson, David L (2019). Bacterial identification using an Absciex 5800 TOF/TOF MALDI research instrument and an external database. Journal of Microbiological Methods, 164 105685, 105685. doi: 10.1016/j.mimet.2019.105685
Williamson, Deborah A, Howden, Benjamin P and Paterson, David L (2019). The risk of resistance: what are the major antimicrobial resistance threats facing Australia?. Medical Journal of Australia, 211 (3), 103-105.e1. doi: 10.5694/mja2.50249
White, Nicole M., Barnett, Adrian G., Hall, Lisa, Mitchell, Brett G., Farrington, Alison, Halton, Kate, Paterson, David L., Riley, Thomas V., Gardner, Anne, Page, Katie, Gericke, Christian A. and Graves, Nicholas (2019). Cost-effectiveness of an environmental cleaning bundle for reducing healthcare associated infections. Clinical Infectious Diseases, 70 (12), 2461-2468. doi: 10.1093/cid/ciz717
Bordin, Amanda, Trembizki, Ella, Windsor, Madeline, Wee, Rachel, Tan, Lit Yeen, Buckley, Cameron, Syrmis, Melanie, Bergh, Haakon, Cottrell, Kyra, Zowawi, Hosam M., Sidjabat, Hanna E, Harris, Patrick N. A., Nimmo, Graeme R., Paterson, David L. and Whiley, David M. (2019). Evaluation of the SpeeDx Carba (beta) multiplex real-time PCR assay for detection of NDM, KPC, OXA-48-like, IMP-4-like and VIM carbapenemase genes. BMC Infectious Diseases, 19 (1) 571, 571. doi: 10.1186/s12879-019-4176-z
Burkett, Ellen, Carpenter, Christopher R., Arendts, Glenn, Hullick, Carolyn, Paterson, David L. and Caterino, Jeffrey M. (2019). Diagnosis of urinary tract infection in older persons in the emergency department: to pee or not to pee, that is the question. Emergency Medicine Australasia, 31 (5) 1742-6723.13376, 856-862. doi: 10.1111/1742-6723.13376
Evans, Scott R., Follmann, Dean, Liu, Ying, Holland, Thomas, Doernberg, Sarah B., Rouphael, Nadine, Hamasaki, Toshimitsu, Jiang, Yunyun, Lok, Judith J., Tran, Thuy Tien T., Harris, Anthony D., Fowler, Vance G., Boucher, Helen, Kreiswirth, Barry N., Bonomo, Robert A., Van Duin, David, Paterson, David L. and Chambers, Henry (2019). Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS). Clinical Infectious Diseases, 68 (11), 1961-1967. doi: 10.1093/cid/ciy912
Lin, Yu-Wei, Rahim, Nusaibah Abdul, Zhao, Jinxin, Han, Mei-Ling, Yu, Heidi H., Wickremasinghe, Hasini, Chen, Ke, Wang, Jiping, Paterson, David L., Zhu, Yan, Rao, Gauri G., Zhou, Qi Tony, Forrest, Alan, Velkov, Tony and Li, Jian (2019). Novel polymyxin combination with the antiretroviral xidovudine exerts synergistic killing against NDM-producing multidrug-resistant Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy, 63 (4) e02176-18. doi: 10.1128/AAC.02176-18
Mitchell, Brett G., Hall, Lisa, White, Nicole, Barnett, Adrian G., Halton, Kate, Paterson, David L., Riley, Thomas V., Gardner, Anne, Page, Katie, Farrington, Alison, Gericke, Christian A. and Graves, Nicholas (2019). An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial. The Lancet Infectious Diseases, 19 (4), 410-418. doi: 10.1016/S1473-3099(18)30714-X
Lipman, Jeffrey, Brett, Stephen J., De Waele, Jan J., Cotta, Menino O., Davis, Joshua S., Finfer, Simon, Glass, Parisa, Knowles, Serena, McGuinness, Shay, Myburgh, John, Paterson, David L., Peake, Sandra, Rajbhandari, Dorrilyn, Rhodes, Andrew, Roberts, Jason A., Shirwadkar, Charudatt, Starr, Therese, Taylor, Colman, Billot, Laurent and Dulhunty, Joel M. (2019). A protocol for a phase 3 multicentre randomised controlled trial of continuous versus intermittent β-lactam antibiotic infusion in critically ill patients with sepsis: BLING III. Critical Care and Resuscitation, 21 (1), 63-68. doi: 10.1016/s1441-2772(23)00582-3
Cameron, Jessica K., Hall, Lisa, Tong, Steven Y. C., Paterson, David L. and Halton, Kate (2019). Incidence of community onset MRSA in Australia: least reported where it is most prevalent. Antimicrobial Resistance and Infection Control, 8 (1) 33, 33. doi: 10.1186/s13756-019-0485-7
Harris, Patrick N. A., Tambyah, Paul and Paterson, David L. (2019). Antibiotics for ceftriaxone resistant gram-negative bacterial bloodstream infections-reply. The Journal of the American Medical Association, 321 (6), 613-614. doi: 10.1001/jama.2018.19353
Isler, Burcu, Doi, Yohei, Bonomo, Robert A. and Paterson, David L. (2019). New treatment options against carbapenem-resistant Acinetobacter baumannii infections. Antimicrobial Agents and Chemotherapy, 63 (1). doi: 10.1128/AAC.01110-18
Peri, Anna Maria, Doi, Yohei, Potoski, Brian A., Harris, Patrick N.A., Paterson, David L. and Righi, Elda (2019). Antimicrobial treatment challenges in the era of carbapenem resistance. Diagnostic Microbiology and Infectious Disease, 94 (4), 413-425. doi: 10.1016/j.diagmicrobio.2019.01.020
Choudhury, Md Abu, Sidjabat, Hanna E., Zowawi, Hosam M., Marsh, Nicole, Larsen, E., Runnegar, N., Paterson, David L., McMillan, David J. and Rickard, Claire M. (2019). Skin colonization at peripheral intravenous catheter insertion sites increases the risk of catheter colonization and infection. American Journal of Infection Control, 47 (12), 1484-1488. doi: 10.1016/j.ajic.2019.06.002
Avent, Minyon L., Rogers, Benjamin A., Cheng, Allen C., Athan, Eugene, Francis, Joshua R., Roberts, Matthew J., Paterson, David L. and Harris, Patrick N. A. (2018). Fosfomycin: what was old is new again. Internal Medicine Journal, 48 (12), 1425-1429. doi: 10.1111/imj.14122
Shen, Cong, Feng, Siyuan, Chen, Hongtao, Dai, Min, Paterson, David L., Zheng, Xiaobin, Wu, Xingui, Zhong, Lan-Lan, Liu, Yan, Xia, Yong, Ma, Rui, Huang, Xi and Tian, Guo-Bao (2018). Transmission of mcr-1-Producing Multidrug-resistant Enterobacteriaceae in Public Transportation in Guangzhou, China. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 67 (2), S217-S224. doi: 10.1093/cid/ciy661
Henderson, A., Tan, E., McCarthy, K. L. and Paterson, D. L. (2018). Activity of ceftolozane/tazobactam against a collection of Pseudomonas aeruginosa isolates from bloodstream infections in Australia. Pathology, 50 (7), 748-752. doi: 10.1016/j.pathol.2018.08.009
Paterson, David L., Wright, Hugh and Harris, Patrick N.A. (2018). Health risks of flood disasters. Clinical Infectious Diseases, 67 (9), 1450-1454. doi: 10.1093/cid/ciy227
Forde, Brian M., Zowawi, Hosam M., Harris, Patrick N. A., Roberts, Leah, Ibrahim, Emad, Shaikh, Nissar, Deshmukh, Anand, Sid Ahmed, Mazen A., Al Maslamani, Muna, Cottrell, Kyra, Trembizki, Ella, Sundac, Lana, Yu, Heidi H., Li, Jian, Schembri, Mark A., Whiley, David M., Paterson, David L. and Beatson, Scott A. (2018). Discovery of mcr-1-mediated colistin resistance in a highly virulent Escherichia coli lineage. mSphere, 3 (5) e00486-18. doi: 10.1128/msphere.00486-18
Harris, Patrick N. A., Tambyah, Paul A., Lye, David C., Mo, Yin, Lee, Tau H., Yilmaz, Mesut, Alenazi, Thamer H., Arabi, Yaseen, Falcone, Marco, Bassetti, Matteo, Righi, Elda, Rogers, Benjamin A., Kanj, Souha, Bhally, Hasan, Iredell, Jon, Mendelson, Marc, Boyles, Tom H., Looke, David, Miyakis, Spiros, Walls, Genevieve, Al Khamis, Mohammed, Zikri, Ahmed, Crowe, Amy, Ingram, Paul, Daneman, Nick, Griffin, Paul, Athan, Eugene, Lorenc, Penelope, Baker, Peter ... MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2018). Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with E coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance: a randomized clinical trial. JAMA, 320 (10), 984-994. doi: 10.1001/jama.2018.12163
Stewart, Adam, Harris, Patrick, Henderson, Andrew and Paterson, David (2018). Treatment of infections with OXA-48 producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy, 62 (11) e01195-18, AAC.01195-18. doi: 10.1128/aac.01195-18
Xu, Yongchang, Zhong, Lan-Lan, Srinivas, Swaminath, Sun, Jian, Huang, Man, Paterson, David L., Lei, Sheng, Lin, Jingxia, Li, Xin, Tang, Zichen, Feng, Siyuan, Shen, Cong, Tian, Guo-Bao and Feng, Youjun (2018). Spread of MCR-3 Colistin Resistance in China: An Epidemiological, Genomic and Mechanistic Study. EBioMedicine, 34, 139-157. doi: 10.1016/j.ebiom.2018.07.027
Russo, A., Falcone, M., Gutiérrez-Gutiérrez, B., Calbo, E., Almirante, B., Viale, P. L., Oliver, A., Ruiz-Garbajosa, P., Gasch, O., Gozalo, M., Pitout, J., Akova, M., Peña, C., Cisneros, J. M., Hernández-Torres, A., Farcomeni, A., Prim, N., Origüen, J., Bou, G., Tacconelli, E., Tumbarello, M., Hamprecht, A., Karaiskos, I., de la Calle, C., Pérez, F., Schwaber, M. J., Bermejo, J., Lowman, W., Hsueh, P.-R. ... REIPI/ESGBIS/INCREMENT investigators (2018). Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. International Journal of Antimicrobial Agents, 52 (5), 577-585. doi: 10.1016/j.ijantimicag.2018.06.018
McCarthy, K. L., Wailan, A. M., Jennison, A. V., Kidd, T. J. and Paterson, D. L. (2018). P. aeruginosa blood stream infection isolates: a "full house" of virulence genes in isolates associated with rapid patient death and patient survival. Microbial Pathogenesis, 119, 81-85. doi: 10.1016/j.micpath.2018.03.062
McNamara, John F., Righi, Elda, Wright, Hugh, Hartel, Gunter F., Harris, Patrick N. A. and Paterson, David L. (2018). Long-term morbidity and mortality following bloodstream infection: a systematic literature review. The Journal of Infection, 77 (1), 1-8. doi: 10.1016/j.jinf.2018.03.005
Zowawi, Hosam M., Syrmis, Melanie W., Kidd, Timothy J., Balkhy, Hanan H., Walsh, Timothy R., Al Johani, Sameera M., Al Jindan, Reem Y., Alfaresi, Mubarak, Ibrahim, Emad, Al-Jardani, Amina, Al Salman, Jameela, Dashti, Ali A., Sidjabat, Hanna E., Baz, Omar, Trembizki, Ella, Whiley, David M. and Paterson, David L. (2018). Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region. Journal of Medical Microbiology, 67 (6) 000730, 846-853. doi: 10.1099/jmm.0.000730
Scheuerman, Oded, Schechner, Vered, Carmeli, Yehuda, Gutiérrez-Gutiérrez, Belen, Calbo, Esther, Almirante, Benito, Viale, Pier-Luigy, Oliver, Antonio, Ruiz-Garbajosa, Patricia, Gasch, Oriol, Gozalo, Monica, Pitout, Johann, Akova, Murat, Peña, Carmen, Molina, Jose, Hernández-Torres, Alicia, Venditti, Mario, Prim, Nuria, Origüen, Julia, Bou, German, Tacconelli, Evelina, Tumbarello, Maria, Hamprecht, Axel, Karaiskos, Ilias, de la Calle, Cristina, Pérez, Federico, Schwaber, Mitchell J., Bermejo, Joaquin, Lowman, Warren ... Rodríguez-Baño, Jesus (2018). Comparison of predictors and mortality between bloodstream infections caused by ESBL-producing Escherichia coli and ESBL-producing Klebsiella pneumoniae. Infection Control and Hospital Epidemiology, 39 (6), 1-8. doi: 10.1017/ice.2018.63
Mitchell, Brett G., White, Nicole, Farrington, Alison, Allen, Michelle, Page, Katie, Gardner, Anne, Halton, Kate, Riley, Thomas V., Gericke, Christian A, Paterson, David L., Graves, Nicholas and Hall, Lisa (2018). Changes in knowledge and attitudes of hospital environmental services staff: The researching effective approaches to cleaning in hospitals (REACH) study. American Journal of Infection Control, 46 (9), 980-985. doi: 10.1016/j.ajic.2018.02.003
Avery, Robin K, Silveira, Fernanda P, Benedict, Kaitlin, Cleveland, Angela Ahlquist, Kauffman, Carol A, Schuster, Mindy G, Dubberke, Erik R, Husain, Shahid, Paterson, David, Chiller, Tom and Pappas, Peter (2018). Cytomegalovirus Infections in Lung and Hematopoietic Cell Transplant Recipients in the Organ Transplant Infection Prevention and Detection (OTIP) Study: a Multi-Year, Multi-Center Prospective Cohort Study. Transplant Infectious Disease , 20 (3) e12877, e12877. doi: 10.1111/tid.12877
Sidjabat, Hanna E., Gien, Jolene, Kvaskoff, David, Ashman, Keith, Vaswani, Kanchan, Reed, Sarah, McGeary, Ross P., Paterson, David L., Bordin, Amanda and Schenk, Gerhard (2018). The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure. Scientific Reports, 8 (1) 3871, 3871. doi: 10.1038/s41598-018-21984-9
Tacconelli, Evelina, Carrara, Elena, Savoldi, Alessia, Harbarth, Stephan, Mendelson, Marc, Monnet, Dominique L, Pulcini, Céline, Kahlmeter, Gunnar, Kluytmans, Jan, Carmeli, Yehuda, Ouellette, Marc, Outterson, Kevin, Patel, Jean, Cavaleri, Marco, Cox, Edward M, Houchens, Chris R, Grayson, M Lindsay, Hansen, Paul, Singh, Nalini, Theuretzbacher, Ursula, Magrini, Nicola, Aboderin, Aaron Oladipo, Al-Abri, Seif Salem, Awang Jalil, Nordiah, Benzonana, Nur, Bhattacharya, Sanjay, Brink, Adrian John, Burkert, Francesco Robert, Cars, Otto ... Zorzet, Anna (2018). Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. The Lancet Infectious Diseases, 18 (3), 318-327. doi: 10.1016/S1473-3099(17)30753-3
Yadav, Rajbharan, Rogers, Kate E., Bergen, Phillip J., Bulitta, Jürgen B., Kirkpatrick, Carl M. J., Wallis, Steven C., Paterson, David L., Nation, Roger L., Lipman, Jeffrey, Roberts, Jason A. and Landersdorfer, Cornelia B. (2018). Optimization and evaluation of piperacillin plus tobramycin combination dosage regimens againstfor patients with altered pharmacokineticsthe hollow-fiber infection model and mechanism-based modeling. Antimicrobial Agents and Chemotherapy, 62 (5) e00078, e00078-18. doi: 10.1128/AAC.00078-18
Djoko, Karrera Y., Achard, Maud E. S., Phan, Minh-Duy, Lo, Alvin W., Miraula, Manfredi, Prombhul, Sasiprapa, Hancock, Steven J., Peters, Kate M., Sidjabat, Hanna E., Harris, Patrick N., Mitić, Nataša, Walsh, Timothy R., Anderson, Gregory J., Shafer, William M., Paterson, David L., Schenk, Gerhard, McEwan, Alastair G. and Schembri, Mark A. (2018). Copper ions and coordination complexes as novel carbapenem adjuvants. Antimicrobial Agents and Chemotherapy, 62 (2) e02280-17. doi: 10.1128/AAC.02280-17
Bergen, Phillip J., Bulitta, Jürgen B., Sime, Fekade B., Lipman, Jeffrey, McGregor, Megan J., Millen, Nada, Paterson, David L., Kirkpatrick, Carl M. J., Roberts, Jason A. and Landersdorfer, Cornelia B. (2018). Differences in suppression of regrowth and resistance despite similar initial bacterial killing for meropenem and piperacillin/tazobactam against Pseudomonas aeruginosa and Escherichia coli. Diagnostic Microbiology and Infectious Disease, 91 (1), 69-76. doi: 10.1016/j.diagmicrobio.2017.12.019
Blaskovich, Mark A T, Hansford, Karl A., Gong, Yujing, Butler, Mark S., Muldoon, Craig, Huang, Johnny X., Ramu, Soumya, Silva, Alberto B., Cheng, Mu, Kavanagh, Angela M., Ziora, Zyta, Premraj, Rajaratnam, Lindahl, Fredrik, Bradford, Tanya A., Lee, June C., Karoli, Tomislav, Pelingon, Ruby, Edwards, David J., Amado, Maite, Elliott, Alysha G, Phetsang, Wanida, Daud, Noor Huda, Deecke, Johan E, Sidjabat, Hanna E, Ramaologa, Sefetogi, Zuegg, Johannes, Betley, Jason R, Beevers, Andrew P G, Smith, Richard A G ... Cooper, Matthew A. (2018). Protein-inspired antibiotics active against vancomycin- and daptomycin-resistant bacteria. Nature Communications, 9 (1) 02123, 22. doi: 10.1038/s41467-017-02123-w
Harris, Patrick N. A., Ben Zakour, Nouri L., Roberts, Leah W., Wailan, Alexander M., Zowawi, Hosam M., Tambyah, Paul A., Lye, David C., Jureen, Roland, Lee, Tau H., Yin, Mo, Izharuddin, Ezlyn, Looke, David, Runnegar, Naomi, Rogers, Benjamin, Bhally, Hasan, Crowe, Amy, Schembri, Mark A., Beatson, Scott A. and Paterson, David L. (2017). Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27. The Journal of Antimicrobial Chemotherapy, 73 (3), 634-642. doi: 10.1093/jac/dkx466
McCarthy, Kate L., Cherian, Jacob D., Avent, Minyon L. and Paterson, David L. (2017). Combination antibiotic therapy for Pseudomonas aeruginosa bacteremia in febrile neutropenic patients? The question still remains. Infectious Diseases, 50 (5), 403-406. doi: 10.1080/23744235.2017.1411605
Palacios-Baena, Zaira Raquel, Gutiérrez-Gutiérrez, Belén, Calbo, Esther, Almirante, Benito, Viale, Pierluigi, Oliver, Antonio, Pintado, Vicente, Gasch, Oriol, Martínez-Martínez, Luis, Pitout, Johann, Akova, Murat, Peña, Carmen, Molina Gil-Bermejo, José, Hernández, Alicia, Venditti, Mario, Prim, Nuria, Bou, German, Tacconelli, Evelina, Tumbarello, Mario, Hamprecht, Axel, Giamarellou, Helen, Almela, Manel, Pérez, Federico, Schwaber, Mitchell J, Bermejo, Joaquín, Lowman, Warren, Hsueh, Po-Ren, Paño-Pardo, José Ramón, Torre-Cisneros, Julián ... Jové, E. (2017). Empiric therapy with carbapenem-sparing regimens for bloodstream infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: Results from the INCREMENT cohort. Clinical Infectious Diseases, 65 (10), 1615-1623. doi: 10.1093/cid/cix606
Harris, Patrick N. A., Pezzani, M. Diletta, Gutierrez-Gutierrez, Belen, Viale, Pierluigi, Hsueh, Po-Ren, Ruiz-Garbajosa, Patricia, Venditti, Mario, Tumbarello, Mario, Navarro-Francisco, Carolina, Calbo, Esther, Akova, Murat, Giamarellou, Helen, Oliver, Antonio, Almirante, Benito, Gasch, Oriol, Martinez-Martinez, Luis, Schwaber, Mitchell J., Daikos, George, Pitout, Johann, Pena, Carmen, Hernandez-Torres, Alicia, Doi, Yohei, Perez, Federico, Tuon, Felipe Francisco, Tacconelli, Evelina, Carmeli, Yehuda, Bonomo, Robert A., Pascual, Alvaro, Paterson, David L. and Rodriguez-Bano, Jesus (2017). Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. International Journal of Antimicrobial Agents, 50 (5), 664-672. doi: 10.1016/j.ijantimicag.2017.08.005
Phan, Minh-Duy, Nhu, Nguyen Thi Khanh, Achard, Maud E. S., Forde, Brian M., Hong, Kar Wai, Chong, Teik Min, Yin, Wai-Fong, Chan, Kok-Gan, West, Nicholas P., Walker, Mark J., Paterson, David L., Beatson, Scott A. and Schembri, Mark A. (2017). Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli. Journal of Antimicrobial Chemotherapy, 72 (10), 2729-2736. doi: 10.1093/jac/dkx204
Gutierrez-Gutierrez, Belen, Bonomo, Robert A., Carmeli, Yehuda, Paterson, David L., Pascual, Alvaro and Rodriguez-Bano, Jesus (2017). Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae (Reply). Lancet Infectious Diseases, 17 (10), 1020-1021. doi: 10.1016/S1473-3099(17)30522-4
Forrest, Alan, Garonzik, Samira M., Thamlikitkul, Visanu, Giamarellos-Bourboulis, Evangelos J., Paterson, David L., Li, Jian, Silveira, Fernanda P. and Nation, Roger L. (2017). Pharmacokinetic/toxicodynamic analysis of colistin-associated acute kidney injury in critically ill patients. Antimicrobial Agents and Chemotherapy, 61 (11) e01367, e01367-17. doi: 10.1128/AAC.01367-17